Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

(2012) L. Y. A. Chai et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Tasting the fungal cell wall

(2010) Jean-Paul Latgé   CELLULAR MICROBIOLOGY

Invasive aspergillosis in developing countries

(2010) Arunaloke Chakrabarti et al.   MEDICAL MYCOLOGY

Proteomic and Transcriptomic Analysis of Aspergillus fumigatus on Exposure to Amphotericin B

(2008) P. Gautam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changes in causes of death over time after treatment for invasive aspergillosis

(2008) John R. Wingard et al.   CANCER

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE